Basecamp Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Sell
253
-124
-33% -$10.5K ﹤0.01% 818
2026
Q1
$32.5K Buy
377
+60
+19% +$5.38K 0.01% 663
2025
Q4
$27.7K Buy
+317
New +$24.1K 0.01% 687

Other funds holding GMED

Basecamp Wealth Advisors's GMED Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Globus Medical (GMED) stake by 33% in Q2 2026, selling an estimated $10.5K and leaving 253 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #818.

Basecamp Wealth Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.5K in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Basecamp Wealth Advisors held 253 shares of Globus Medical worth $20K as of Q2 2026.
  • Basecamp Wealth Advisors sold 124 Globus Medical shares in Q2 2026, an estimated $10.5K.
  • Globus Medical made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #818 holding.
  • Basecamp Wealth Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Globus Medical position peaked at $32.5K in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.